GPX4 and breast cancer: For example, genes such as acyl-CoA synthetase long-chain family member 4 (ACSL4) and GPX4 have been shown to serve as independent predictors of chemosensitivity in neoadjuvant chemotherapy for breast cancer, and their expression levels are strongly associated with patient prognosis (75).